Pemetrexed (intrathecal)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pemetrexed (intrathecal), covering 2019-12-26 to 2024-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI [Phase 2]